The Division of Pharmacoepidemiology & Pharmacoeconomics at the Brigham and Women’s Hospital includes faculty and staff with backgrounds in internal medicine and its subspecialties, as well as epidemiology, health services research and policy, geriatrics, biostatistics, decision science, and public health. Major areas of research include: the scientific, policy, and social factors that influence physicians’ drug choices; medication compliance by patients; the identification and prevention of adverse drug effects; programs to improve the appropriateness of prescribing and drug taking; and pharmaceutical cost-effectiveness analysis. The Division also serves as a resource to the Brigham on appropriate medication use, and helps train its interns and residents in making optimal prescribing decisions.
Faculty Web Pages
- Jonathan Darrow discusses precision medicines at the National Press Club (Washington, D.C.)
- Jessica Franklin and Sebastian Schneeweiss talked with Pinksheets about their new FDA-funded study to evaluate the use of real world data for regulatory decision-making
- Dr. Sebastian Schneeweiss presents at the US National Academies of Sciences, Engineering, and Medicine on when databases studies can support regulatory decision making
- Division members launch the website for the Harvard Program on Perinatal and Pediatric Pharmacoepidemiology (H4P)
- DoPE Annual Report 2016
- Dr. Mike Fralick discusses a recent Big Data study on The Rounds Table